XTL Biopharmaceuticals

XTLBNASDAQ
$2.40
0.14.35%
Last update: Jul 1, 9:14 AM
15 minutes delayed

XTL Biopharmaceuticals (NASDAQ:XTLB) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Get Alert
No data available to display

FAQ

Q

What is the most recent guidance for XTL Biopharmaceuticals (XTLB)?

A

There have been no specific sales or earnings guidance reported for XTL Biopharmaceuticals in recent months.

Browse guidance and forecast on all stocks.

People Also Watch